Navigation Links
Scientific breakthrough: International collaboration has sequence salmon genome
Date:6/10/2014

Vancouver, BC - Today the International Cooperation to Sequence the Atlantic Salmon Genome (ICSASG) announced completion of a fully mapped and openly accessible salmon genome. This reference genome will provide crucial information to fish managers to improve the production and sustainability of aquaculture operations, and address challenges around conservation of wild stocks, preservation of at-risk fish populations and environmental sustainability. This breakthrough was announced at the International Conference on Integrative Salmonid Biology (ICISB) being held in Vancouver this week.

Salmonids are an important piece of the economic and social fabric of communities on BC's coastline and many other countries including Norway and Chile. The fisheries and aquaculture sector is one of the economic engines of BC: seafood is the province's largest agri-food export, contributing $870 million of the province's total agri-food exports of $2.5 billion. High value species such as salmon make a significant economic contribution to the economy. Canada's Atlantic salmon related aquaculture revenues exceed $600 million annually and BC is the only province with a commercial salmon fishery.

Salmonids are also a key species for research and while some salmon genetic information is known, many fundamental questions have remained: a fully assembled reference sequence available for researchers worldwide will have a major impact on revealing information about salmon and other salmonids, such as rainbow trout and Pacific salmon.

Viruses and pathogens are a challenging hazard to livelihoods and economies dependent on salmon and this sequence provides real support to improve the production of salmonids in a sustainable way. Other benefits of the salmon sequence include applications for food security and traceability and broodstock selection for commercially important traits. Healthier food, more environmentally sound fish farming and better interactions with wild salmon are all positive outcomes from this research.

"Knowledge of the whole genome makes it possible to see how genes interact with each other, and examine the exact gene that governs a certain trait such as resistance against a particular disease," says Dr. Steinar Bergseth, Chair of the International Steering Committee for the ICSASG. "The development of vaccines and targeted treatment is much closer."

The international collaboration involves researchers, funding bodies and industry from Canada, Chile and Norway. The successful completion of the salmon genome provides a basis for continued partnerships between these and other countries involved in research and industrial development of salmonids.

"A better scientific understanding of this species and its genome is a critical step towards improving the growth and management of global fisheries and aquaculture," says Dr. Alan Winter, President & CEO of Genome BC. "Additionally, the level of international collaboration seen in this project is a testament to the importance of global coordination to address challenges too big for any one country individually."

The aquaculture industries need to produce healthy food in a sustainable and efficient manner to be in line with the consumer demands. "The knowledge of the sequence will certainly give us a long awaited tool to achieve this" says Petter Arnesen, Breeding Director of Marine Harvest, Norway.


'/>"/>

Contact: Jennifer Boon
jboon@genomebc.ca
778-327-8374
Genome BC
Source:Eurekalert

Related biology news :

1. APS issues new policy requiring identification of sex or gender in reporting scientific research
2. Strong scientific evidence that eating berries benefits the brain
3. Flavor and the new Nordic cuisine: BioMed Centrals new scientific journal Flavor is launched
4. 3-D RNA modeling opens scientific doors
5. UC Riverside plant cell biologist receives top scientific honor
6. Womens scientific achievements often overlooked and undervalued
7. FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisor Board
8. FirstMark Welcomes Renowned Cardiologist and Researcher Dr. Prediman K. Shah to Scientific Advisory Board
9. NTU researchers study little mighty creature for scientific breakthrough
10. Scientific meeting at Virginia Tech will make more than $2 million economic impact
11. CRN assesses current state of scientific research for nutritional supplements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
(Date:2/13/2017)... 2017 Former 9/11 Commission border counsel and ... Janice Kephart of Identity Strategy Partners, LLP, today ... "Executive Order: Protecting the Nation From Foreign Terrorist ... "As President Trump,s ,Travel Ban, Executive Order gains ... banned the travel ban, it is important that our ...
(Date:2/8/2017)... 7, 2017  Aware, Inc. (NASDAQ: AWRE ), ... financial results for its quarter and year ended December 31, ... 2016 was $3.9 million compared to $6.9 million in the ... of 2016 was $0.6 million compared to $2.6 million in ... quarter of 2016 was $0.5 million, or $0.02 per diluted ...
Breaking Biology News(10 mins):
(Date:2/28/2017)...  Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company ... autoimmune diseases, asthma and allergic diseases and cancer, ... and full year ended December 31, 2016 and ... and clinical highlights. "During 2016, we ... by starting five clinical trials across our XmAb ...
(Date:2/28/2017)... ... February 28, 2017 , ... FireflySci is a small cuvette manufacturer ... late 2014, FFS had a mission to bring affordable and quality lab equipment to ... product that gives a lab everything needed to get started with using cuvettes. , ...
(Date:2/28/2017)... ... February 28, 2017 , ... ACEA Biosciences, a pioneer in cell analysis instrumentation ... Dr. Roger (Feng) Luo as the new Vice President of Global Clinical Development. ... drug companies, Dr. Luo will now team with Dr. Li Xu, Chief Medical Officer, ...
(Date:2/28/2017)... ... February 28, 2017 , ... GigaGen ... from millions-diverse immune repertoires, today announced a strategic partnership with Trianni, Inc. ... to express human antibodies. The partnership will use GigaGen technology to discover immuno-oncology ...
Breaking Biology Technology: